Normal Healthy Volunteers

3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
3
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

US WorldMeds
US WorldMedsKY - Louisville
2 programs
2
LofexidinePhase 11 trial
Lofexidine hydrochloridePhase 11 trial
Active Trials
NCT04188730Completed16Est. Mar 2021
NCT01629446Completed6Est. Jun 2012
Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
1 program
1
Oral methylnaltrexonePhase 11 trial
Active Trials
NCT01366339CompletedEst. Dec 2003

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
US WorldMedsLofexidine
US WorldMedsLofexidine hydrochloride
Bausch HealthOral methylnaltrexone

Clinical Trials (3)

Total enrollment: 22 patients across 3 trials

A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution

Start: Feb 2021Est. completion: Mar 202116 patients
Phase 1Completed
NCT01629446US WorldMedsLofexidine hydrochloride

Lofexidine Mass Balance in Volunteers

Start: May 2012Est. completion: Jun 20126 patients
Phase 1Completed
NCT01366339Bausch HealthOral methylnaltrexone

Tolerance and Pharmacokinetics Study of MNTX Tablets

Start: Oct 2003Est. completion: Dec 2003
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space